Filtered By:
Procedure: HPV Testing
Vaccination: Vaccines
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 366 results found since Jan 2013.
Shift in harms and benefits of cervical cancer screening in the era of HPV screening and vaccination: A modelling study
CONCLUSION: Both harms and benefits of hrHPV screening decrease over the first screening rounds. For younger women the efficiency will decrease, while longer screening intervals lead to increased efficiency in older women. Programme efficiency overall remains stable, this shows the importance of longer intervals for low-risk women.FUNDING: Dutch National Institute for Public Health and the Environment.PMID:35429107 | DOI:10.1111/1471-0528.17190
Source: BJOG : An International Journal of Obstetrics and Gynaecology - April 16, 2022 Category: OBGYN Authors: Sylvia Kaljouw Erik E L Jansen Clare A Aitken Inge M C M de Kok Source Type: research
Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis
CONCLUSIONS: Most studies concluded that HPV vaccination of girls in Latin America countries was cost-saving or cost-effective, despite heterogeneity between models.PMID:35370017 | DOI:10.1016/j.vaccine.2022.03.046
Source: Vaccine - April 4, 2022 Category: Allergy & Immunology Authors: Romina A Tejada Tal ía Malagón Eduardo L Franco Source Type: research
Impact of web-based health education on HPV vaccination uptake among college girl students in Western and Northern China: a follow-up study
CONCLUSION: Female college students' HPV vaccination uptake is insufficient, and they have minimal detailed knowledge about HPV and its vaccines. Web-based health education on HPV vaccines is an easy, feasible, and effective way to improve the awareness and acceptance of HPV vaccination among female college students, but it has limited effect on HPV vaccination uptake.PMID:35197068 | DOI:10.1186/s12905-022-01625-0
Source: Cancer Control - February 24, 2022 Category: Cancer & Oncology Authors: Xi Zhang Hui Chen Jing Zhou Qian Huang Xiao-Yu Feng Jing Li Source Type: research
Long-term effectiveness of human papillomavirus vaccines among adult women: A real-world scenario
CONCLUSIONS: HPV vaccine effectiveness was high in adult women in a real-world scenario in a developing country. Free HPV vaccination in adult women in this age group should be further explored when vaccine supplies are not limited. (HPV: human papillomavirus. LSIL+: low-grade squamous intraepithelial lesion or worse. ASC-US+: atypical squamous cells of undetermined significance or worse).PMID:35190207 | DOI:10.1016/j.vaccine.2022.02.042
Source: Vaccine - February 22, 2022 Category: Allergy & Immunology Authors: Ga Young Lee Perapong Inthasorn Piyawat Laowahutanont Saranath Lawpoolsri Supitcha Kamolratanakul Palita Lungchukiet Juhwan Oh Wichai Termrungruanglert Nimit Taechakraichana Punnee Pitisuttithum Source Type: research
When and How Would You Screen This Patient for Cervical Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Ann Intern Med. 2022 Feb 8. doi: 10.7326/M21-4372. Online ahead of print.ABSTRACTSuccessful screening programs based on cervical cytology have dramatically reduced the incidence of cervical cancer in the United States. Human papillomavirus immunization is poised to reduce it further as an increasing percentage of vaccinated women reach adulthood. A recent guideline from the American Cancer Society advises that cervical cancer screening begin at age 25 and that high-risk human papillomavirus testing is the preferred screening test. The U.S. Preventive Services Task Force recommends screening begin at age 21 and that cytolog...
Source: Annals of Internal Medicine - February 7, 2022 Category: Internal Medicine Authors: Eileen E Reynolds Amy Weinstein Huma Farid Howard Libman Source Type: research
Age-specific outcomes from the first round of HPV screening in unvaccinated women: observational study from the English cervical screening pilot
CONCLUSIONS: These data provide a reliable reference for future epidemiological studies, including those concerning the effectiveness of HPV vaccination.PMID:34913243 | DOI:10.1111/1471-0528.17058
Source: BJOG : An International Journal of Obstetrics and Gynaecology - December 16, 2021 Category: OBGYN Authors: Matejka Rebolj Christopher S Mathews Francesca Pesola Kate Cuschieri Karin Denton Henry Kitchener HPV Pilot Steering Group Source Type: research
